<乌鸦传媒>Coronary Disease That Comes With a Donor Heart Does Carry Risk Study shows cardiovascular consequences but not overall mortality impact Aug 22, 2023
<乌鸦传媒>Who Is to Blame for the Rampant Overtreatment of Peripheral Artery Disease? The loudest critics are the biggest offenders Aug 13, 2023
<乌鸦传媒>American Guidelines Sour on Beta-Blockers for Chronic Coronary Disease For some people, revascularization to improve symptoms or help survival also endorsed Jul 20, 2023
<乌鸦传媒>Subclinical CVD Detected in Kids With Higher Arsenic Burden Local Superfund site may contribute to inorganic arsenic exposure Jun 30, 2023
<乌鸦传媒>Protocol Optimizing Meds for T2D and CVD Pushed Beyond Cardiology Alone Endocrinologists urged to pay attention to COORDINATE trial Jun 27, 2023
<乌鸦传媒>Colchicine's Rebirth as Cardiovascular Drug Approved by FDA Repurposed anti-inflammatory drug may be used alone or in combination with standard meds Jun 20, 2023
<乌鸦传媒>No Increase in Major Cardiac Events With Testosterone-Replacement Therapy Men with hypogonadism and heart disease or risk factors saw no increased risk vs placebo Jun 16, 2023
<乌鸦传媒>Novel Long-Lesion DES Sails Through Pivotal Trial 48-mm Xience stent surprised with low restenosis at 1 year May 21, 2023
<乌鸦传媒>Door Shut on Excess Noncardiac Deaths After Intervention for Stable CAD Earlier signal of noncardiovascular mortality refuted by large meta-analysis May 19, 2023
<乌鸦传媒>Bioresorbable Scaffold Concept Evolves Into 'Revolutionary' Hybrid Early results promising with DynamX bioadaptor, though traditional BRS hasn't been abandoned May 19, 2023
<乌鸦传媒>GLP-1 Agonists Come Out on Top in Cardiovascular Comparison of Newer Diabetes Meds Serious limitations noted of attempt to compare GLP-1 agonists, SGLT-2 inhibitors, however May 08, 2023
<乌鸦传媒>Common Diuretic Pauses Atherosclerosis in CKD, T2D If finerenone isn't available, try spironolactone, said researcher Apr 15, 2023
<乌鸦传媒>Subclinical Coronary Plaques Still Boost MI Risk Natural history study lays the groundwork for intervention trials Mar 28, 2023
<乌鸦传媒>Statin Users Show LDL Doesn't Come Close to Telling Whole Story of ASCVD Residual inflammation is important factor of cardiovascular risk Mar 07, 2023
<乌鸦传媒>Early Promise for PCSK9 Inhibition in Severe COVID-19 Effects observed in inflammation and improved clinical outcomes Jan 17, 2023
<乌鸦传媒>Dementia Accompanying Cardiometabolic Disease: Does It Come Down to Genetics? Twin study suggests special monitoring in some individuals Dec 29, 2022
<乌鸦传媒>Is Red Meat Consumption Bad for You? Not on the basis of increased dietary saturated fat, the Skeptical Cardiologist finds Dec 03, 2022
<乌鸦传媒>Study Refutes Heart Health Claims of Dietary Supplements LDL cholesterol reductions with cinnamon, garlic, and others not on par with statin Nov 06, 2022
<乌鸦传媒>Keeping Plavix After Short DAPT: Bleeding Benefit Emerges a Few Years After PCI Antiplatelet strategy has good results in longer follow-up of SMART-CHOICE trial Sep 29, 2022
<乌鸦传媒>PCI vs CABG: Does Age Inform Choice for Left Main Coronary Artery Disease? Swedish registry study contributes to ongoing controversy Sep 19, 2022
<乌鸦传媒>P2Y12 Inhibitors May Be the Better Option for Secondary Prevention in CAD Meta-analysis challenges central role of aspirin, researcher says Aug 30, 2022
<乌鸦传媒>Pendulum Swings Back for FFR-Guided Complete Revascularization Modality helps avoid unnecessary intervention in heart attack patients with multivessel disease Aug 29, 2022
<乌鸦传媒>PCI Flops for Ischemic LV Dysfunction With Coronary Artery Disease Randomized trial provides "definitive" evidence against revascularizing stable cases Aug 27, 2022
<乌鸦传媒>Mass Cardiovascular Testing May Add Years for Some Men Mixed results after the DANCAVAS program from Denmark Aug 27, 2022
<乌鸦传媒>Should You Really Eat Two Servings of Fatty Fish a Week? The Skeptical Cardiologist weighs the science behind the recommendation Aug 25, 2022
<乌鸦传媒>How to Avoid the Unnecessary Cardiovascular Operations of Philip Roth's 'Everyman' The Skeptical Cardiologist discusses the book's lessons for patients Aug 21, 2022
<乌鸦传媒>Stenting Hits Another Wall in Intracranial Stenosis Stroke Trial disappoints, but another hints at benefit for tirofiban in this stroke population Aug 09, 2022
<乌鸦传媒>Heart Disease Will Surge Over the Coming Decades Worsening racial disparities are also projected Aug 01, 2022
<乌鸦传媒>Bye-Bye, 'Life's Simple 7': AHA Redefines Cardiovascular Health by Adding Sleep New metrics and scoring algorithm for heart health in children and adults Jun 29, 2022
<乌鸦传媒>Chronic Total Occlusion PCI Is Getting Safer -- At Least Until the Pandemic Registry illuminates trends in success, complications May 21, 2022
<乌鸦传媒>Special Shielding Could Fix Cath Lab Staff's Radiation and Orthopedic Issues "Like walking on the moon," researcher says of doing cases without lead aprons May 21, 2022
<乌鸦传媒>Seven Factors Account for 85% of Acute MI Risk in Young Americans Some factors were sex-specific, highlighting need for targeted interventions, say investigators May 03, 2022
<乌鸦传媒>Two PCI Guidance Strategies on Par for Intermediate Coronary Stenosis FLAVOUR trial weighs in on FFR versus IVUS Apr 05, 2022
<乌鸦传媒>Higher-Dose ANGPTL3 Inhibitor Cuts Lipids but With Questionable Safety Significant safety signals in dose-ranging trial may end drug's future in CV prevention Apr 03, 2022
<乌鸦传媒>More Evidence for Prehab Before Cardiac Surgery One center's initial experience suggests good perioperative results Feb 02, 2022
<乌鸦传媒>Multi-Arterial Grafting Inches Upward in Surgeon Adoption Learning curve holds strong in CABG technique Jan 30, 2022
<乌鸦传媒>Novel Krill Oil Cuts Severe High Triglycerides Post-hoc pooled analysis of phase III trials favors omega-3 fatty acid formula Jan 06, 2022
<乌鸦传媒>FDA Approves Cholesterol-Lowering siRNA Therapy PCSK9 inhibitor inclisiran to become available in early 2022 Dec 22, 2021
<乌鸦传媒>Oral PCSK9 Inhibitor Slashed Cholesterol Reductions of 65% observed in phase I trials Nov 16, 2021
<乌鸦传媒>Adenosine-Free Alternative to FFR Bolstered by Longer-Term Data Physiological index boasts good 5-year results in iFR-SWEDEHEART Nov 05, 2021
